Helen Viban, NP

NPI: 1598020877
Total Payments
$961.44
2024 Payments
$43.68
Companies
8
Transactions
42

Payment Breakdown by Category

Food & Beverage$914.53 (95.1%)
Education$46.91 (4.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $914.53 41 95.1%
Education $46.91 1 4.9%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $329.18 14 $0 (2024)
ITI, Inc. $266.11 12 $0 (2022)
Otsuka America Pharmaceutical, Inc. $122.97 6 $0 (2023)
Sunovion Pharmaceuticals Inc. $104.68 4 $0 (2021)
Neurocrine Biosciences, Inc. $54.95 2 $0 (2023)
Janssen Pharmaceuticals, Inc $42.04 2 $0 (2021)
E.R. Squibb & Sons, L.L.C. $26.10 1 $0 (2024)
Alkermes, Inc. $15.41 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $43.68 2 E.R. Squibb & Sons, L.L.C. ($26.10)
2023 $327.91 13 ABBVIE INC. ($234.71)
2022 $183.54 8 ITI, Inc. ($159.78)
2021 $406.31 19 ITI, Inc. ($106.33)

All Payment Transactions

42 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/02/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $26.10 General
Category: Psychiatry/Psychology
09/17/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $17.58 General
Category: NEUROSCIENCE
10/03/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $21.81 General
Category: NEUROSCIENCE
08/09/2023 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII Food and Beverage In-kind items and services $26.88 General
Category: PSYCHIATRY
07/27/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $28.43 General
Category: NEUROSCIENCE
07/15/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $29.80 General
Category: NEUROSCIENCE
07/08/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $20.63 General
Category: NEUROSCIENCE
06/16/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $31.26 General
Category: NEUROSCIENCE
05/11/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $21.93 General
Category: NEUROSCIENCE
05/02/2023 Otsuka America Pharmaceutical, Inc. REXULTI (Drug), ABILIFY MAINTENA Food and Beverage In-kind items and services $17.72 General
Category: PSYCHIATRY
04/12/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $29.47 General
Category: NEUROSCIENCE
02/15/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $30.98 General
Category: NEUROSCIENCE
02/15/2023 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $26.71 General
Category: Neuropsychiatry
02/03/2023 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $21.89 General
Category: PSYCHIATRY
01/18/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $20.40 General
Category: NEUROSCIENCE
05/12/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $23.76 General
Category: NEUROSCIENCE
05/04/2022 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $26.87 General
Category: PSYCHIATRY
03/04/2022 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $6.45 General
Category: PSYCHIATRY
02/17/2022 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $34.24 General
Category: PSYCHIATRY
02/03/2022 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $19.33 General
Category: PSYCHIATRY
01/26/2022 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $7.07 General
Category: PSYCHIATRY
01/18/2022 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $18.91 General
Category: PSYCHIATRY
01/13/2022 ITI, Inc. CAPLYTA (Drug) Education In-kind items and services $46.91 General
Category: PSYCHIATRY
11/05/2021 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $22.88 General
Category: PSYCHIATRY
06/23/2021 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $16.46 General
Category: Neuroscience

About Helen Viban, NP

Helen Viban, NP is a Registered Nurse healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2012. The National Provider Identifier (NPI) number assigned to this provider is 1598020877.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Helen Viban, NP has received a total of $961.44 in payments from pharmaceutical and medical device companies, with $43.68 received in 2024. These payments were reported across 42 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($914.53).

Practice Information

  • Specialty Registered Nurse
  • Other Specialties Psychiatric/Mental Health
  • Location Washington, DC
  • Active Since 07/11/2012
  • Last Updated 11/17/2023
  • Taxonomy Code 163W00000X
  • Entity Type Individual
  • NPI Number 1598020877

Products in Payments

  • VRAYLAR (Drug) $329.18
  • CAPLYTA (Drug) $266.11
  • ABILIFY MAINTENA (Drug) $105.25
  • LATUDA (Drug) $104.68
  • INGREZZA (Drug) $54.95
  • INVEGA SUSTENNA (Drug) $42.04
  • COBENFY (Drug) $26.10
  • REXULTI (Drug) $17.72
  • ARISTADA (Drug) $15.41

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Registered Nurse Doctors in Washington